start portlet menu bar

Web İçeriği Görüntüleyicisi

Display portlet menu
end portlet menu bar

Characterization of recombinant verotoxin 2e during the production process

Ana Sayfa Bilgi Characterization of recombinant verotoxin 2e during the production process

Characterization of recombinant verotoxin 2e during the production process

In this study, we present the characterization of the production process for the rVt2e. 

Bu makaleyi indir

1,04 MB

Bu makale hakkında

Yayınlanan

IPVS Congress China, 2018

Tarih

13 Tem 2018

Yazarlar

Mallorquí, J.; Ferrer-Soler, L.; Panosa, C.; Bau, M.; Moreno, A.; Ruiz, M; Sitja, M.

Özet

The purification step used in the rVt2e production process is essential in order to obtain a final rVt2e protein with a purity higher than 90% and with low endotoxin levels.

İlgili ürünler

VEPURED®

İlgili yayınlar

Possible association between the use of zinc oxide in pre-starter feed and verocheck Effects of VEPURED® on production on a vt2e-positive farm without clinical signs or mortality related to oedema disease Weaned piglet mortality and antibiotic treatment reduction in a belgian pig farm by vaccination with VEPURED®

Paylaşın

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar

Characterization of recombinant verotoxin 2e

Display portlet menu
end portlet menu bar

İnceleyin

Yayınlar

Efficacy of Suiseng® Diff/A vaccine and its associated use with Suiseng® Coli/C against C....

17-01-2022
Hastalık Özetleri

Pathogenesis of C. difficile

02-02-2022
Haberler

HIPRA at the IPVS 2022

04-07-2022